Advances in Hematological Malignancies
Recent years have witnessed remarkable progress in the field of hematological malignancies. Novel therapies such as targeted agents, immunotherapies, and gene editing are revolutionizing the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative strategies, offering promise for more curative trea